• bladder cancer;
  • prognosis;
  • soft tissues;
  • surgical margin;
  • treatment;
  • urethra

What's known on the subject? and What does the study add?

  • Positive surgical margin (PSM) frequency after radical cystectomy has been estimated to be 4–15%. Studies that have not distinguished between the different sites of PSM have failed to show that they are an independent prognostic factor for disease-free survival. Only perivesical soft tissue PSMs have been associated with an increased risk of cancer recurrence and cancer-specific death.
  • This is the first comprehensive published analysis of PSMs occurring during radical cystectomy for pTx pN0 M0 bladder cancer according to their location, comparing their cancer-specific survival (CSS) and other outcomes with those of a control group paired according to TNM status, age, sex and urinary diversion method. Local recurrence-free survival rates were found to be lower in patients with both soft tissue and urethral PSMs. Moreover, soft-tissue PSMs were associated with lower metastatic recurrence-free and CSS rates.


  • To compare the prognoses associated with positive surgical margins (PSMs) according to their urethral, ureteric and/or soft tissue locations in patients with pN0 M0 bladder cancer who have not undergone neoadjuvant chemotherapy.

Patients and Methods

  • A retrospective, case–control study was conducted between 1991 and 2011 using data from 17 academic centres in France.
  • A total of 154 patients (cases) with PSMs met the eligibility criteria and were matched according to centre, pT stage, gender, age and urinary diversion method with a population-based sample of 154 patients (controls) from 3651 patients who had undergone cystectomies.
  • The median follow-up period was 23.9 months.
  • Multivariable Cox regression analysis was used to test the effects of PSMs on local recurrence (LR)-free survival, metastatic recurrence (MR)-free survival and cancer-specific survival (CSS).


  • The 5-year LR-free survival and CSS rates of patients with urethral and soft tissue PSMs were lower than those in the control group.
  • A significant decrease in CSS was associated with soft tissue PSMs (P = 0.003, odds ratio = 0.425, 95% confidence interval 0.283–0.647). The prognosis was not affected in cases of ureteric PSMs.


  • Soft tissue PSMs were associated with poor CSS rates in patients with pN0 M0 bladder cancer.
  • A correlation between urethrectomy and a reduction of the risk of LR in a urethral PSM setting was observed.